Frost & Sullivan
Frost & Sullivan provides analysis to assist clients in evaluating the rapidly evolving mobile communications industry landscape and develop successful market development and penetration strategies. Frost & Sullivan’s research covers the entire value chain that creates the foundation for this market: Next-Generation Mobile Networks, Emerging Mobile Applications, Value-Added Content & Services, Next Generation Mobile Devices & Billing Systems and OSS. The core of our research is aimed at strategically analyzing each individual piece of this foundation and the role it plays in determining the ultimate goal of the market--Creating a communication environment that is compelling in nature and highly conducive to growth.



Mobile Enterprise Magazine
Mobile Enterprise Magazine and MobileEnterpriseMag.com are targeted at today's decision-makers charged with implementing mobile technologies into the business processes of the enterprise. Mobile Enterprise and MobileEnterpriseMag.com serve as strategic guides for mobilizing any company's frontline professionals, including key field service and field sales personnel, as well as top executives and managers.



BIOGEN
Biogen is a global company developing drugs for human health care through genetic engineering and a pioneer in immunology, neurobiology and oncology research. The company, founded in 1978, manages all aspects of research, development, manufacturing and marketing of its products. Biogen develops therapies primarily for autoimmune conditions. Flagship drug AVONEX treats relapsing multiple sclerosis (MS), while another leading drug, AMEVIVE, treats psoriasis. Biogen is also involved in the licensing of its products. Such products include alpha interferon, key to licensee Schering-Plough's PegIntron and Intron A drugs. Biogen licenses a hepatitis B vaccine and other products to Merck, Abbott Labs, and others




Everypath
Everypath is a mobile task automation software company, enabling business critical tasks to be performed on handheld devices to improve user productivity, reduce operating expense and increase management visibility. Our unique approach permits business processes to be extracted from existing applications for use on virtually any mobile device.

Thousands of sales, service and supply chain professionals and over 1 million consumers use Everypath software across a wide range of industries. Our global 1000 customers include leaders such as Toshiba, Biogen, NTT, and E*TRADE with deployments in North America, Japan, and Europe. Everypath is headquartered in Santa Clara, California (http://www.everypath.com/), (800) 238-3797.

Back To Frost